Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Authors
Keywords
Neurotrophin, Neurotrophic factor, Alzheimer’s disease, Meta-analysis, Systematic review
Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 65, Issue 3, Pages 289-300
Publisher
Springer Nature
Online
2018-06-28
DOI
10.1007/s12031-018-1100-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia
- (2017) X-Y Qin et al. MOLECULAR PSYCHIATRY
- Specific protein biomarker patterns for Alzheimer’s disease: improved diagnostics in progress
- (2017) Illana Gozes EPMA Journal
- Glial Cell-Line Derived Neurotrophic Factor (GDNF) Concentrations in Cerebrospinal Fluid and Serum of Patients with Early Alzheimer's Disease and Normal Controls
- (2017) Guido Straten et al. JOURNAL OF ALZHEIMERS DISEASE
- Galanin Protects Amyloid-β-Induced Neurotoxicity on Primary Cultured Hippocampal Neurons of Rats
- (2017) Yong Cheng et al. JOURNAL OF ALZHEIMERS DISEASE
- Altered NCAM Expression Associated with the Cholinergic System in Alzheimer's Disease
- (2017) Bárbara Aisa et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome
- (2016) Kuo-Hsuan Chang et al. CLINICA CHIMICA ACTA
- Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease
- (2016) Scott E. Counts et al. Current Alzheimer Research
- Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer’s Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis
- (2016) Bo Yi Kim et al. MOLECULAR NEUROBIOLOGY
- Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer’s disease: a meta-analysis study (N=7277)
- (2016) X-Y Qin et al. MOLECULAR PSYCHIATRY
- Circulating insulin-like growth factor 1 and insulin-like growth factor binding protein-3 level in Alzheimer’s disease: a meta-analysis
- (2016) Xiaohui Hu et al. NEUROLOGICAL SCIENCES
- Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease
- (2016) S-S Jiao et al. Translational Psychiatry
- Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer’s Disease
- (2016) Philip P. Ostrowski et al. PLoS One
- The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease
- (2015) M. Florencia Iulita et al. Current Alzheimer Research
- Cerebrospinal fluid biomarkers for Alzheimerʼs disease
- (2015) Henrik Zetterberg CURRENT OPINION IN PSYCHIATRY
- Brain-derived neurotrophic factor and TrkB expression in the “oldest-old,” the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta
- (2015) Bernadeta Michalski et al. NEUROBIOLOGY OF AGING
- Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease
- (2015) Orestes Vicente Forlenza et al. NEUROMOLECULAR MEDICINE
- The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
- (2015) Josiane Budni et al. Aging and Disease
- New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
- (2014) Miguel Medina et al. BIOCHEMICAL PHARMACOLOGY
- Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer’s disease in patients with the apolipoprotein E ε4 genotype
- (2014) Chao Wang et al. BIOMARKERS
- The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer’s Disease: Possible Therapeutic Implications
- (2014) Johanna Zemva et al. CNS & Neurological Disorders-Drug Targets
- Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease
- (2014) Mayara Chaves Faria et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
- (2014) A Masi et al. MOLECULAR PSYCHIATRY
- ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice
- (2013) C Tiveron et al. CELL DEATH AND DIFFERENTIATION
- Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?
- (2013) Zaira Esposito et al. CNS Neuroscience & Therapeutics
- Early BDNF Treatment Ameliorates Cell Loss in the Entorhinal Cortex of APP Transgenic Mice
- (2013) A. H. Nagahara et al. JOURNAL OF NEUROSCIENCE
- Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis
- (2013) B S Fernandes et al. MOLECULAR PSYCHIATRY
- proNGF Inhibits Neurogenesis and Induces Glial Activation in Adult Mouse Dentate Gyrus
- (2013) Jingjing Guo et al. NEUROCHEMICAL RESEARCH
- Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment
- (2013) Li Huang et al. NEUROSCIENCE LETTERS
- The role of neurotrophins in major depressive disorder
- (2013) Cheng Jiang et al. Translational Neuroscience
- Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia
- (2013) Galit Weinstein et al. JAMA Neurology
- Hippocampal ProNGF Signaling Pathways and β-Amyloid Levels in Mild Cognitive Impairment and Alzheimer Disease
- (2012) Elliott J. Mufson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
- (2012) Maria Björkqvist et al. PLoS One
- Decreased serum angiogenin level in Alzheimer's disease
- (2012) Yong Nam Kim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Potential therapeutic uses of BDNF in neurological and psychiatric disorders
- (2011) Alan H. Nagahara et al. NATURE REVIEWS DRUG DISCOVERY
- Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
- (2011) Rebecca Craig-Schapiro et al. PLoS One
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
- (2010) F. Angelucci et al. Current Alzheimer Research
- Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients
- (2010) Christoph Laske et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- ProNGF mediates death of Natural Killer cells through activation of the p75NTR–sortilin complex
- (2010) Mary-Louise Rogers et al. JOURNAL OF NEUROIMMUNOLOGY
- Brain-derived neurotrophic factor inhibits cell cycle reentry but not endoplasmic reticulum stress in cultured neurons following oxidative or excitotoxic stress
- (2010) Nadia Boutahar et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats
- (2010) Y. Jiang et al. NEUROSCIENCE
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- ProNGF induces TNFα-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway
- (2010) Frédéric Lebrun-Julien et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- New Insights in the Biology of BDNF Synthesis and Release: Implications in CNS Function
- (2009) M. E. Greenberg et al. JOURNAL OF NEUROSCIENCE
- Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease
- (2009) Josef Marksteiner et al. NEUROBIOLOGY OF AGING
- Effects of proNGF on Neuronal Viability, Neurite Growth and Amyloid-beta Metabolism
- (2009) Yan-Jiang Wang et al. NEUROTOXICITY RESEARCH
- Memory loss in Alzheimer’s disease: implications for development of therapeutics
- (2008) Carl A Gold et al. Expert Review of Neurotherapeutics
- Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats
- (2008) S. Arancibia et al. NEUROBIOLOGY OF DISEASE
- Analysis of Cerebrospinal Fluid of Alzheimer Patients
- (2008) Josef Marksteiner et al. PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search